ERROR! No headcode.htm file found.

School of Medicine


Showing 1-6 of 6 Results

  • Ali Raza Khaki, MD

    Ali Raza Khaki, MD

    Clinical Assistant Professor, Medicine - Oncology

    Bio Dr. Khaki is a hematologist/oncologist with board certification in oncology, hematology, and internal medicine. He is also a clinical assistant professor of oncology at Stanford University School of Medicine.

    In his clinical practice, he treats patients all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. With each patient, he is devoted to providing exceptional, humanistic care. As a medical student, he was named to the national Gold Humanism Honor Society. As a resident, he received the Reza Gandjei Humanism Award.

    His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He also has studied health care utilization and costs for end-of-life care of cancer patients.

    Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.

    He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. His work has appeared in publications including JAMA Oncology, Cancer Investigation, Clinical Genitourinary Cancer, the Journal of Urology, and Lancet. In addition, he is an editor for HemOnc.org and theMednet, the physician-only online community where members share clinical questions and answers.

    Dr. Khaki is a member of the American Society of Clinical Oncology, American Society of Hematology, Multinational Association of Supportive Care in Cancer, and American Medical Informatics Association. He is on the Measure Steering Group committee and the Trainee and Early Career Council committee of the American Society of Clinical Oncology.

  • Saad A. Khan, MD

    Saad A. Khan, MD

    Assistant Professor of Medicine (Oncology)

    Bio Saad A. Khan, MD is a medical oncologist focused on the treatment of head and neck, thyroid and lung cancers. His research interests include therapeutic clinical trials as well as mechanisms of reducing toxicities that patients experience. His research activities include ongoing clinical trials of targeted and immune therapy in aggressive thyroid malignancies. He is a member of the NRG Head and Neck Committee, the ECOG Head and Neck Core and Thoracic Committees and the National Cancer Institute?s Head and Neck Steering Committee Rare Tumor Task Force.

    When not in clinic or the hospital he enjoys spending time with his family and 3 children, hiking and sitting on the beach.

  • Youn H Kim, MD

    Youn H Kim, MD

    The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)

    Current Research and Scholarly Interests Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.

  • Allison W. Kurian, M.D., M.Sc.

    Allison W. Kurian, M.D., M.Sc.

    Professor of Medicine (Oncology) and of Epidemiology and Population Health

    Current Research and Scholarly Interests I aim to improve the outcomes of women's cancers through clinically-oriented research on genetic risk assessment, risk-adapted screening and prevention.

  • David Kurtz

    David Kurtz

    Assistant Professor of Medicine (Oncology)

    Current Research and Scholarly Interests Implementation of noninvasive detection of malignancies in the clinic remains difficult due to both technical and clinical challenges. These include necessary improvements in sensitivity and specificity of biomarkers, as well as demonstration of clinical utility of these assays. My research focuses on technical development and implementation of assays to detect and track cancers in order to facilitate personalized disease management.

Stanford Medicine Resources: